Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 20/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28952286 | 0.83 | GLP1R (0.40) | GLP1R | |
| SCHEMBL24599392 | 0.83 | GLP1R (0.40) | GLP1R | |
| SCHEMBL25025228 | 0.79 | GLP1R (0.40) | GLP1R | |
| SCHEMBL31323121 | 0.78 | GLP1R (0.39) | GLP1R | |
| SCHEMBL28952207 | 0.77 | GLP1R (0.41) | GLP1R | |
| SCHEMBL23749684 | 0.77 | GLP1R (0.41) | GLP1R | |
| SCHEMBL31424397 | 0.76 | GLP1R (0.41) | GLP1R | |
| SCHEMBL20014787 | 0.74 | GLP1R (0.36) | GLP1R | |
| SCHEMBL26122776 | 0.74 | GLP1R (0.36) | GLP1R | |
| SCHEMBL25045565 | 0.74 | THRB (0.33) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174565-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174565-A1 | HETEROCYCLIC GLP-1 AGONISTS | GLP1R, GIPR, GCGR | GLP1R 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.